131 related articles for article (PubMed ID: 34821488)
21. The frequency of eight common point mutations in CYP21 gene in Iranian patients with congenital adrenal hyperplasia.
Ramazani A; Kahrizi K; Razaghiazar M; Mahdieh N; Koppens P
Iran Biomed J; 2008 Jan; 12(1):49-53. PubMed ID: 18392095
[TBL] [Abstract][Full Text] [Related]
22. Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany.
Krone N; Braun A; Roscher AA; Knorr D; Schwarz HP
J Clin Endocrinol Metab; 2000 Mar; 85(3):1059-65. PubMed ID: 10720040
[TBL] [Abstract][Full Text] [Related]
23. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
24. Mutational characterization of congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Malaysia.
Balraj P; Lim PG; Sidek H; Wu LL; Khoo AS
J Endocrinol Invest; 2013 Jun; 36(6):366-74. PubMed ID: 23027774
[TBL] [Abstract][Full Text] [Related]
25. High frequency of Q318X mutation in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency in northeast Brazil.
Campos VC; Pereira RM; Torres N; Castro Md; Aguiar-Oliveira MH
Arq Bras Endocrinol Metabol; 2009 Feb; 53(1):40-6. PubMed ID: 19347184
[TBL] [Abstract][Full Text] [Related]
26. [Identification of point mutations in the 21-hydroxylase gene in patients affected with congenital adrenal hyperplasia].
Fonseca D; Gutiérrez A; Silva C; Coll M; Malo G; Orjuela C; Arteaga C; Giraldo A
Biomedica; 2005 Jun; 25(2):220-30. PubMed ID: 16022377
[TBL] [Abstract][Full Text] [Related]
27. 21-Hydroxylase and 11beta-hydroxylase mutations in Romanian patients with classic congenital adrenal hyperplasia.
Grigorescu Sido A; Weber MM; Grigorescu Sido P; Clausmeyer S; Heinrich U; Schulze E
J Clin Endocrinol Metab; 2005 Oct; 90(10):5769-73. PubMed ID: 16046588
[TBL] [Abstract][Full Text] [Related]
28. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
29. Genotype-phenotype correlation study and mutational and hormonal analysis in a Chinese cohort with 21-hydroxylase deficiency.
Xu C; Jia W; Cheng X; Ying H; Chen J; Xu J; Guan Q; Zhou X; Zheng D; Li G; Zhao J
Mol Genet Genomic Med; 2019 Jun; 7(6):e671. PubMed ID: 30968594
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Finkielstain GP; Chen W; Mehta SP; Fujimura FK; Hanna RM; Van Ryzin C; McDonnell NB; Merke DP
J Clin Endocrinol Metab; 2011 Jan; 96(1):E161-72. PubMed ID: 20926536
[TBL] [Abstract][Full Text] [Related]
31. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency.
Wilson RC; Nimkarn S; Dumic M; Obeid J; Azar MR; Najmabadi H; Saffari F; New MI
Mol Genet Metab; 2007 Apr; 90(4):414-21. PubMed ID: 17275379
[TBL] [Abstract][Full Text] [Related]
32. Analysis of phenotypes and genotypes in 84 patients with 21-Hydroxylase deficiency in southern China.
Hou L; Liang L; Lin S; Ou H; Liu Z; Huang S; Zhang L; Meng Z
Steroids; 2019 Nov; 151():108474. PubMed ID: 31446012
[TBL] [Abstract][Full Text] [Related]
33. Mutation analysis of the CYP21A2 gene in congenital adrenal hyperplasia.
Forouzanfar K; Seifi M; Hashemi-Gorji F; Karimi N; Estiar MA; Karimoei M; Sakhinia E; Karimipour M; Ghergherehchi R
Cell Mol Biol (Noisy-le-grand); 2015 Aug; 61(4):51-5. PubMed ID: 26278268
[TBL] [Abstract][Full Text] [Related]
34. Common CYP21 gene mutations in Czech patients and statistical analysis of worldwide mutation distribution.
Kotaska K; Lisá L; Průsa R
Cent Eur J Public Health; 2003 Sep; 11(3):124-8. PubMed ID: 14514162
[TBL] [Abstract][Full Text] [Related]
35. [Molecular and clinical study on homozygous or heterozygous large deletion of
Gao YJ; Yu BQ; Lu L; Tong AL; Chen S; Mao JF; Wang X; Wu XY; Nie M
Zhonghua Yi Xue Za Zhi; 2019 Mar; 99(12):912-917. PubMed ID: 30917440
[No Abstract] [Full Text] [Related]
36. 21-hydroxylase deficiency-induced congenital adrenal hyperplasia in 230 Chinese patients: Genotype-phenotype correlation and identification of nine novel mutations.
Wang R; Yu Y; Ye J; Han L; Qiu W; Zhang H; Liang L; Gong Z; Wang L; Gu X
Steroids; 2016 Apr; 108():47-55. PubMed ID: 26804566
[TBL] [Abstract][Full Text] [Related]
37. Rare mutations in the CYP21A2 gene detected in congenital adrenal hyperplasia.
Neocleous V; Ioannou YS; Bartsota M; Costi C; Skordis N; Phylactou LA
Clin Biochem; 2009 Sep; 42(13-14):1363-7. PubMed ID: 19501079
[TBL] [Abstract][Full Text] [Related]
38. Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia.
Ferenczi A; Garami M; Kiss E; Pék M; Sasvári-Székely M; Barta C; Staub M; Sólyom J; Fekete G
J Clin Endocrinol Metab; 1999 Jul; 84(7):2369-72. PubMed ID: 10404805
[TBL] [Abstract][Full Text] [Related]
39. [Molecular characterization of mutations and phenotype/genotype correlation in Chinese patients with 21-hydroxylase deficiency].
Zhang B; Lu ZL; Wang Y; Tao H
Yi Chuan Xue Bao; 2004 Sep; 31(9):950-5. PubMed ID: 15493145
[TBL] [Abstract][Full Text] [Related]
40. Mutation analysis of the CYP21A2 gene in the Iranian population.
Rabbani B; Mahdieh N; Ashtiani MT; Larijani B; Akbari MT; New M; Parsa A; Schouten JP; Rabbani A
Genet Test Mol Biomarkers; 2012 Feb; 16(2):82-90. PubMed ID: 22017335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
